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carcinoma: report of two cases
Hua Guo1,2,3, Yan Shen1,2,3, Wei-Lin Wang1,2,3, Min Zhang1,2,3, Hong Li1,2,3, Ying-Sheng Wu1,2,3, Sheng Yan1,2,3,
Xiao Xu1,2,3, Jian Wu1,2,3 and Shu-Sen Zheng1,2,3*Abstract
Castleman disease (CD) is an uncommon benign lymphoproliferative disorder, which usually presents as solitary or
multiple masses in the mediastinum. Peripancreatic CD was rarely reported. Herein, we report two cases of
unicentric peripancreatic CD from our center. A 43-year-old man and a 58-year-old woman were detected to have
a pancreatic mass in the routine medical examinations. Both of them were asymptomatic. The computed
tomography and ultrasonographic examination revealed a mild enhancing solitary mass at the pancreatic head/
neck. No definite preoperative diagnosis was established and Whipple operations were originally planned. The
intraoperative frozen section diagnosis of both patients revealed lymphoproliferation. Then the local excisions of
mass were performed. Histological examination revealed features of CD of hyaline-vascular type. No recurrence was
found during the follow-up period. CD should be included in the differential diagnosis of pancreatic tumors. Local
excision is a suitable surgical choice.
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Castleman disease (CD) is an uncommon benign lym-
phoproliferative disorder of unknown etiology. It was
first described by Castleman in 1956 [1]. There are three
pathologic variants: hyaline vascular CD, plasma cell
CD, and mixed type of CD is characterized that a patient
had features of both hyaline vascular and plasma cell
types of CD [2]. Plasmablastic variant of CD, which was
considered as a subvariant of plasma cell type, occurs
predominantly in immunosuppressed patients and
human immunodeficiency virus (HIV)-positive patients
[3]. Clinically, CD may present in the forms of unicentric
and multicentric. The unicentric variant of CD (UCD) is
the most common form of the disease, which is confined
to a single lymph-node chain or area, with hyaline vas-
cular type. It is often asymptomatic and curable by sur-
gical excision of the mass. The multicentric variant of
CD (MCD) is a less common but more aggressive form.* Correspondence: shusenzheng@zju.edu.cn
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reproduction in any medium, provided the orIts corresponding histological pattern is usually the
plasma cell and mixed type [3]. Unicentric peripancrea-
tic CD was rarely reported in the published literature.
Herein, we report two cases of unicentric peripancreatic
CD of hyaline vascular type from our center.Case presentation
Case 1: a 43-year-old man visited to us with an abdom-
inal mass detected by ultrasonographic examination in a
routine medical examination. He had a history of IgA
nephropathy for 1 year. The preoperative serum creatin-
ine was slightly elevated. The patient was asymptomatic
with a normal appetite, no vomiting, no abdominal pain,
no jaundice, and no weight loss. The tumor markers
CEA, AFP, and CA125 were normal, the CA 19–9 was
54.8 U/mL(normal range, 0–37 U/mL). Chest X-ray was
normal. As the serum creatinine was slightly elevated,
the unenhanced computed tomography (CT) and
contrast-enhanced ultrasonography were performed, the
result showed a 3 × 2.1 cm, well-demarcated, mass at the
pancreatic head (Figure 1).
Case 2: a 58-year-old woman with no remarkable med-
ical history visited our hospital with a mass detected by
ultrasonographic examination in a routine examination.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Image findings of case 1. Case1: Axial unenhanced computed tomography of abdomen depicts a 3 × 2.1cm mass (arrows) at
pancreatic head (A). Contrast-enhanced ultrasonography reveals a solitary mass that homogeneous intense enhancement after contrast material
administration (B,C).
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were within normal limits and a chest X-ray was normal.
Tumor markers CEA, AFP, and CA125 were normal, the
CA 19–9 was 46.4 U/mL. Contrast-enhanced CT
showed a 4 × 2.7 cm, well-demarcated, mild enhancing
mass at the pancreatic neck (Figure 2).
Both patients were asymptomatic. The image findings
revealed a mass in pancreas, preoperative tumor marker
CA 19–9 were slightly elevated. Both were mimicked
carcinoma of pancreas, and Whipple operations wereFigure 2 Image findings of case 2. Case 2: Axial contrast-enhanced CT im
mass (arrows) at pancreatic neck. Axial unenhanced (A), arterial phase (B), a
ultrasonography (D).planned before the operation. Intraoperatively, the
masses were found closely adhere to pancreas. The
masses were encapsulated and well demarcated from
the attached pancreatic tissue. Thorough exploration
revealed no intra-abdominal lymphadenopathy or any
visceral abnormalities. The intraoperative frozen section
diagnosis of both patients revealed lymphoproliferation.
Then the original plan was changed, the local excisions
of the masses were performed to avoid a more morbidity
manner of the Whipple operation. The postoperativeage of the abdomen depicts a 4 × 2.7 cm moderately enhancing
nd delayed phase (C) CT images of the abdomen and
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hyaline-vascular type of CD. Hematoxylin-eosin (HE)
stains showed typical paracortical expansion with mixed
inflammatory cells, and a prominent proliferation of
blood vessels. High-power photomicrograph of one area
showed a germinal center with the classic ‘onionskin’ ap-
pearance (Figure 3). The tumor markers were re-
examined 1month after the operation, and the CA 19–9
in both patients were within normal range.
Discussion
The etiology and pathophysiologic basis of CD remains
unclear until now. The chronic inflammation, immuno-
deficiency state, and autoimmune disorders (such as
viral infection involving the human herpes virus 8, the
Epstein-Barr virus, or autoimmune hemolytic anemia)
are considered to be the possible causal factors of CD.
The dysregulation of inflammatory mediators, particu-
larly interleukin-6 (IL-6) secretion has become the lead-
ing theory explaining constitutional symptoms and
laboratory abnormalities [4,5]. Of the two patients, case1
was diagnosed as IgA nephropathy which considered an
autoimmune disease, and received steroid treatment, but
case2 had no inflammatory or autoimmunity disorder.
Komatsuda et al. [6] reported a patient who developed
UCD during the course of immunosuppressive therapy
for IgA nephropathy associated with cutaneous nodules,
the symptoms and abnormal laboratory findings were
improved after anti-interleukin-6 receptor antibody ad-
ministration. Whether case1 with peripancratic CD wasFigure 3 Histological findings. Typical histologic features of Castleman d
hematoxylin-eosin stained photo-micrograph shows typical paracortical exp
and plasma cells, and a prominent proliferation of blood vessels(original m
photomicrograph (original magnification,×200) of one area shows a germinassociated with IgA nephropathy or immunosuppressive
therapy was uncertain.
Clinically, CD is usually divided into unicentric and
multicentric types. The UCD is most common with Hya-
line vascular type. The mass is usually asymptomatic
and localized, and is discovered incidentally, although
some patients present with fever, fatigue, and localized
pressure symptoms from the mass. The histological find-
ings are of a multiple germinal center surrounded by cir-
cumferentially arranged layers in an onionskin pattern,
of small lymphocytes, with a prominent vascular stroma
and occasional plasma cells, which are characteristic of
hyaline-vascular disease.
The preoperative diagnosis of the CD is very difficult.
CD most commonly presents as a solitary mass. The clas-
sic CT appearance of hyaline vascular CD is that of a soli-
tary enlarged lymph node or localized nodal mass that
demonstrate homogeneous intense enhancement after
contrast material administration. Diagnostic image some-
times mimics malignancy and CD cannot be identified be-
cause of the lack of disease specific signs. Some case
reports had introduced an endoscopic ultrasound-guided
fine needle aspiration (EUS-FNA) to establish the diagno-
sis of CD preoperatively [7,8], however, the sensitivity and
specificity of this manner still had not been confirmed by
large sample random clinical trial. The diagnosis of CD
was still mostly dependent on the postoperative histo-
logical examination. Our two patients were both mim-
icked as carcinoma of pancreas so the preoperative
cytologic examinations were not performed.isease with hyaline vascular variant(case1:A1-A3; case2 B1-B3)
ansion with mixed inflammatory cells, including mature lymphocytes
agnification A1,B1: ×40; A2,B2: ×100; A3,B3: ×200). High-power
al center with the classic ‘onionskin’ appearance.
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feron-α or anti-IL-6 antibodies), and combination
chemotherapy have all been used to manage the disease
[4]. Complete surgical excision remains the most used
treatment strategy for unicentric CD, which confers a
cure rate approaching 100% [9]. When the lesion is com-
pletely removed the prognosis is always perfect. If
complete resection is difficult, partial resection may also
be helpful, the recurrence rate after subtotal resection is
also low [10]. Recurrence of CD after surgical excisions
is rarely reported, even if the patients show recurrence,
the disease remains progression-free after a repeat resec-
tion [11]. Extended surgery, which might cause more
morbidity, is not required because CD was considered as
a benign procedure. Radiotherapy or chemotherapy may
be helpful, but it is not curative and the results vary
[12]. Neoadjuvant use of rituximab [13] and neoadjuvant
radiotherapy [14] have been reported in the treatment of
irresectable unicentric CD to reduce tumor size and vas-
cularity to allow for a less morbid surgical resection. In
the two patients, during the intraoperative exploration,
the occupation was found solitary, and the masses were
encapsulated and well demarcated from the attached
pancreatic tissue. The intraoperative frozen section diag-
nosis revealed lymphoproliferation. So the original surgi-
cal plans were changed, the Whipple resectiongiven up,
and the mildmorbidity local excisions were performed,
respectively. When the pathology results were available,
chest CT scan and neck ultrasound scan were tested to
confirm the tumors were unicentric. The postoperative
courses were uneventful. No recurrence was found dur-
ing the follow-up period. Interestingly, preoperative CA
19–9 of the two patients were slightly elevated, and the
CA 19–9 levels were reduced to normal range after the
tumor excision. Whether the elevation of serum CA 19–
9 level correlated with the CD needs more evidences.
Conclusions
In conclusion, CD should be included in the differential
diagnosis of pancreatic tumors. Preoperative and intrao-
perative differential diagnosis of CD is important. The
less morbidity local excision is a suitable surgical choice.
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